OMB.report

Federal forms, ICRs, and supporting documents

Information Collection Request

Preferences for Longer-Acting Preexposure Prophylaxis (PrEP) Methods Among Persons in US Populations at Highest Need: A Discrete Choice Experiment

ICR 202209-0920-019 · OMB 0920-1400 · Received in OIRA

Forms and Documents
DocumentTypeStatusAvailability
Form 0920 C4P Provider DCE Survey Form and Instruction New Available
Form 0920 Provider Screening & Consent Form and Instruction New Repair queued
Form 0920 C4P Client DCE Survey Form and Instruction New Repair queued
Form 0920 Client Screening & Consent Form and Instruction New Available
Att 4 Provider Invitation Email.docx Supplementary Document Uploaded 2022-09-26 Repair queued
Att 3 Client Invitation Email.docx Supplementary Document Uploaded 2022-09-26 Repair queued
Att 10 PIA_signed.pdf Supplementary Document Uploaded 2022-09-26 Repair queued
Att 9 RTI IRB Approval Notice.pdf Supplementary Document Uploaded 2022-09-26 Repair queued
Att 1 Authorizing Legislation.docx Supplementary Document Uploaded 2022-09-26 Repair queued
SS Part B_C4P.docx Supporting Statement B Uploaded 2022-09-26 Repair queued
SS Part A.docx Supporting Statement A Uploaded 2022-09-26 Repair queued
IC Document Collections
IC IDCollectionTypeStatusForm
256139 C4P Provider DCE Survey Form and Instruction New
256138 Provider Screening & Consent Form and Instruction New
256137 C4P Client DCE Survey Form and Instruction New
256136 Client Screening & Consent Form and Instruction New
ICR Details
202209-0920-019
Received in OIRA
HHS/CDC 0920-22CX
Preferences for Longer-Acting Preexposure Prophylaxis (PrEP) Methods Among Persons in US Populations at Highest Need: A Discrete Choice Experiment
New collection (Request for a new OMB Control Number)   No
Regular 10/17/2022
  Requested Previously Approved
24 Months From Approved
11,040 0
2,282 0
0 0
The goal of this study is to understand preferences for long-acting pre-exposure prophylaxis (LA-PrEP) products for HIV prevention among potential users and providers, including product characteristics and other service delivery factors that may facilitate or hinder future update of these products. Data will be collected via two separate self-administered online cross-sectional surveys; one for potential LA-PrEP users and one for clinicians. The study design is comprised of a discrete choice experiment (DCE) and additional questions to directly elicit participant preferences. Results from this experiment will be used to identify key factors for adoption and implementation of LA-PrEP products.
PL: Pub.L. 301 - 241 Research and Investigations Name of Law: Public Health Service Act
  
None
Not associated with rulemaking
  87 FR 11445 03/01/2022
87 FR 61327 10/11/2022
No
  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 11,040 0 0 11,040 0 0
Annual Time Burden (Hours) 2,282 0 0 2,282 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new data/information collection.
$646,424
Yes Part B of Supporting Statement
    Yes
    No
No
No
No
No
Thelma Sims 4046394771
  No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
10/17/2022